Comparison of In Vitro Phosphate-Binding Studies of Sevelamer Carbonate Using Incubator Shaker and USP Dissolution Apparatus II

被引:0
作者
Tibon, Natasha Stella [1 ]
Allada, Ravikiran [1 ]
Vakkala, Sudhakar [1 ]
Muthudoss, Prakash [2 ]
Shahnawaz, Sajid Syed [1 ]
机构
[1] Novugen Pharma, Res & Dev Dept, Shah Alam, Selangor, Malaysia
[2] Oncogen Pharma, Adv Analyt Lab, Shah Alam, Selangor, Malaysia
来源
DISSOLUTION TECHNOLOGIES | 2022年 / 29卷 / 02期
关键词
Sevelamer carbonate; phosphate binding; dissolution; ion chromatography; HYPERPHOSPHATEMIA; PREVENTION; PH;
D O I
10.14227/DT290222P78
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the case of most phosphate-binding agents, in vitro phosphate-binding studies are essential for establishing bioequivalence between generic and reference drug formulations. Traditionally, an incubator shaker is used to conduct phosphate-binding studies, but this method is limited by manual sample collection and associated variability. This study aims to evaluate an automatic sampling method using a dissolution tester as an alternative to incubator shakers. Kinetic phosphate-binding studies of sevelamer carbonate tablets (test and reference formulations) were performed using an incubator shaker and USP dissolution apparatus 2. The results from both methods were compared. Though both formulations were equivalent in terms of the phosphate-binding capacity in both methods, the automatic sampling method using the dissolution apparatus had less variability than the manual sampling method using the incubator shaker. Thus, the dissolution apparatus is preferred for bioequivalence and interchangeability studies of sevelamer carbonate tablets.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 10 条
[1]  
[Anonymous], 2015, DRAFT GUIDANCE SEVEL
[2]   Hydrodynamic investigation of USP dissolution test apparatus II [J].
Bai, Ge ;
Armenante, Piero M. ;
Plank, Russell V. ;
Gentzler, Michael ;
Ford, Kenneth ;
Harmon, Paul .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (09) :2327-2349
[3]   Sevelamer Carbonate [J].
Barna, Mary M. ;
Kapoian, Toros ;
O'Mara, Neeta Bahal .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) :127-134
[4]  
Chan S, 2017, AUST PRESCR, V40, P9, DOI 10.18773/austprescr.2017.002
[5]   In-vitro Equilibrium Phosphate Binding Study of Sevelamer Carbonate by UV-Vis Spectrophotometry [J].
Prasaja, Budi ;
Syabani, M. Maulana ;
Sari, Endah ;
Chilmi, Uci ;
Cahyaningsih, Prawitasari ;
Kosasih, Theresia Weliana .
DRUG RESEARCH, 2018, 68 (11) :648-652
[6]   Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study [J].
Schumacher, Stefan P. ;
Schurgers, Leon J. ;
Vervloet, Marc G. ;
Neradova, Aegida .
NEPHROLOGY, 2019, 24 (02) :221-226
[7]  
Spaia S, 2011, HIPPOKRATIA, V15, P22
[8]   Determination of the binding parameter constants of Renagel® capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatography [J].
Swearingen, RA ;
Chen, X ;
Petersen, JS ;
Riley, KS ;
Wang, DH ;
Zhorov, E .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (1-2) :195-201
[9]   Sevelamer and other anion-exchange resins in the prevention and treatment of hyperphosphataemia in chronic renal failure [J].
Wrong, Oliver ;
Harland, Clive .
NEPHRON PHYSIOLOGY, 2007, 107 (01) :17-33
[10]   Evaluation of the In Vitro Efficacy of Sevelamer Hydrochloride and Sevelamer Carbonate [J].
Yang, Yongsheng ;
Mohammad, Adil ;
Berendt, Robert T. ;
Carlin, Alan ;
Khan, Mansoor A. ;
Faustino, Patrick J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (02) :864-875